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Introduction
Sub-Saharan Africa consists of 43 countries south of the Sahara (Figure 1). This area spans 
latitudes 13°N to 33°S with an average annual daytime temperature of 21 °C. The UV Index is 
often higher than 10 (extreme) and rarely drops below 7, except at high altitudes and towards the 
tip of South Africa in the winter months (June, July and August). The land varies from equatorial 
rainforest to dry woodland, savannah, grassland and mountain grassland. 
The major beneficial outcome of solar ultraviolet radiation (UVR) exposure on human health lies 
in the endogenous production of vitamin D, while adverse outcomes of excess exposure include 
skin cancers and eye diseases.1 Extensive research and public health interventions relating 
to the consequences of solar UVR on human health have been carried out in many developed 
countries; however, the same is not true for sub-Saharan Africa. Limited information suggests 
health and exposure risks do exist in this area of the world, although accessing published and 
verified data is a challenge, because most sub-Saharan countries do not have operational health 
information systems or ground-based networks to monitor solar UVR. The aim of this review is 
to broaden the understanding of the effects of solar UVR on human health in sub-Saharan Africa 
by considering an update of relevant health outcomes and by documenting public perceptions 
and interventions. 
Search strategy
A systematic approach was used to identify key published resources of substance and 
appropriate scientific merit. Databases searched were African Journals Online, SABINET, 
Academic Search Premier, Pubmed, SciELO, Medline, JSTOR, Web of Science and Scopus. 
Keywords entered were “solar UV radiation” AND health AND [country]; “sun exposure” AND 
health AND [country]; sunburn AND [country]; “skin cancer” AND [country]; albinism AND 
“sun exposure” AND [country]; [range of sun-related eye diseases] AND “sun exposure” AND 
[country]; “sun protection” AND [country]; “sun behaviour” AND [country]; and “sunsmart 
awareness programme” AND [country]. Reference lists of collected articles including reports of 
the World Health Organization (WHO) were examined. Using the same keywords, Google was 
searched for grey literature, a particularly important source in the African context. The websites 
of national departments of health and cancer associations were investigated for information on 
‘SunSmart’ programmes and sun-related health statistics.
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Photoprotection messages and ‘SunSmart’ programmes exist mainly to prevent skin cancers 
and, more recently, to encourage adequate personal sun exposure to elicit a vitamin D 
response for healthy bone and immune systems. Several developed countries maintain 
intensive research networks and monitor solar UV radiation to support awareness campaigns 
and intervention development. The situation is different in sub-Saharan Africa. Adequate 
empirical evidence of the impact of solar UV radiation on human health, even for melanomas 
and cataracts, is lacking, and is overshadowed by other factors such as communicable 
diseases, especially HIV, AIDS and tuberculosis. In addition, the established photoprotection 
messages used in developed countries have been adopted and implemented in a limited 
number of sub-Saharan countries but with minimal understanding of local conditions and 
behaviours. In this review, we consider the current evidence for sun-related effects on human 
health in sub-Saharan Africa, summarise published research and identify key issues. Data 
on the prevalence of human diseases affected by solar UV radiation in all subpopulations 
are not generally available, financial support is insufficient and the infrastructure to address 
these and other related topics is inadequate. Despite these limitations, considerable progress 
may be made regarding the management of solar UV radiation related health outcomes in 
sub-Saharan Africa, provided researchers collaborate and resources are allocated appropriately. 
Copyright: © 2012. The Authors. Licensee: AOSIS OpenJournals. This work is licensed under the Creative Commons Attribution License.
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Results
Skin cancers 
Sun exposure is the major environmental risk factor for 
melanoma and for the non-melanoma skin cancers (NMSCs), 
basal cell carcinoma (BCC) and squamous cell carcinoma 
(SCC). The lifetime risk of these tumours is low in those 
with black skin and highest in those with fair skin, estimated 
at a difference of up to 60-fold. There are other major 
differences depending on skin colour.2 While BCCs represent 
about 80% of cutaneous tumours in fair-skinned people, 
they are the least common of the skin tumours in deeply 
pigmented people, in whom SCCs are the most frequent. 
In dark-skinned individuals, SCCs occur most often on 
the lower limbs (developing from antecedent lesions such 
as ulcerations, burns and scars), followed by the head and 
neck. In fair-skinned people, SCCs are found almost entirely 
on the most sun-exposed areas of the body, such as the face 
and ears. Unlike the situation in individuals with fair skin, 
the majority of melanomas in black skin occur on a lower 
extremity, particularly on the sole of the foot, a body site with 
little pigmentation.
The occurrence of NMSCs in sub-Saharan Africa is rarely 
monitored. However, the UVR-attributable disease burden 
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FIGURE 1: The countries of sub-Saharan Africa.
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caused by SCCs and BCCs for some of the countries in this 
region was calculated for the year 2000 using three levels 
of skin pigmentation, models for global assessment and 
country-specific population-weighted average daily ambient 
UVR.3,4 Using actual results, the annual incidence of SCC in 
Black individuals was estimated as 1 in 100 000 in a township 
near Soweto, Johannesburg in 1966–1975,5 whereas the age-
standardised annual incidence of BCC in the Netherlands is 
currently more than 140 in 100 000. A study in Kano, Nigeria 
revealed that 6.3% of all cancers in female individuals and 
9.9% in male individuals were NMSCs in 1995–2004.6 One 
recent report based on rural hospitals in Kenya found 
that 44% of all cutaneous malignancies were SCCs and 7% 
were BCCs.7 
For melanoma, which accounts for more than 80% of skin 
cancer deaths, there are also few figures available regarding 
incidence and prevalence for sub-Saharan Africa, although, 
as for the NMSCs, the UV-attributable disease burden from 
this tumour was calculated as approximately 5100 deaths for 
the year 2000 in this area of the world.4 For South Africa, in 
2001 – one of the last years for which statistics are currently 
available – the National Cancer Registry recorded an age-
standardised incidence rate per 100 000 for melanoma of 1.1 
for Black males, 1.5 for Black females, 22.5 for White males 
and 17.4 for White females.8 The incidence has risen since 
then and the South African Cape region was estimated in 
2009 to have the highest incidence of melanoma in the world 
at 69 new cases per 100 000 White individuals9 (Australia has 
65 per 100 000). 
Accurate figures on the prevalence of skin cancers in all 
subpopulations in sub-Saharan Africa are required, especially 
to record any changes in incidence. Such data are needed to 
inform the public regarding photoprotection and to improve 
clinical awareness.
Melasma
Melasma is an uneven hyperpigmentation which appears 
as dark, macular, pigmented patches on the face.10 The 
cause of melasma is complex – genetic, hormonal, therapy 
and lifestyle-related contributions are implicated, as is sun 
exposure. For example, 51% of patients reported sun exposure 
as a triggering factor and 84% reported sun exposure as an 
aggravating factor in a study based in Tunisia, with a high 
lifetime sun exposure increasing the risk of severe melasma 
threefold.11 Melasma represents a significant problem in sub-
Saharan Africa, primarily because of its impact on quality of 
life. It is suggested to have a significant psycho-emotional 
effect on women.12 While different scales, including the 
Melasma Quality of Life scale, have been devised, these have 
not been tailored effectively for the cultural needs of multi-
ethnic subpopulations. 
 
Few statistics are available for sub-Saharan Africa regarding 
the prevalence of other skin disorders induced by either 
acute sun exposure, such as sunburn, or by chronic sun 
exposure, such as photoageing and actinic keratoses, the 
latter recognised as premalignant lesions.
Oculocutaneous albinism
Oculocutaneous albinism (OCA) is a genetically 
inherited, autosomal recessive condition characterised by 
hypopigmentation of the skin, hair and eyes as a result of 
a lack of, or reduced, melanin. There are many people 
living with OCA in sub-Saharan Africa; estimates indicate a 
prevalence of 1 in 4728 in Zimbabwe, 1 in 3900 in South Africa 
and as high as 1 in 1000 in the Tonga tribe in Zimbabwe.13,14 
Individuals with OCA are at increased risk from the adverse 
effects of sun exposure, such as extreme sun sensitivity 
and photophobia. SCCs of the neck and head are the most 
common cutaneous tumours seen in African patients with 
OCA,15 with melanomas occurring rarely.14 
Ophthalmohelioses 
There is a range of eye diseases associated with sunlight 
exposure – ophthalmohelioses. These diseases include 
photoconjunctivitis, photokeratitis and activation of 
ocular herpes simplex virus following acute exposure to 
solar UVR, and NMSCs of the lid and conjunctiva, ocular 
melanoma, pinguecula (local degeneration of conjunctiva), 
pterygium (inflammation, proliferation and invasive growth 
on conjunctiva and cornea), climatic droplet keratopathy 
(epithelial degeneration), age-related cataracts and possibly 
age-related macular degeneration following chronic 
exposure to solar UVR. 
Few data are available for sub-Saharan Africa that estimate the 
scale of health problems caused by these ophthalmohelioses, 
although it is recognised that this area has the highest 
regional burden of blindness at 20% of the world’s blindness 
and only 11% of the world’s population.16 Indeed, 1% of 
Africans are blind.17 Cataracts account for approximately 
50% of the cases of blindness worldwide. The evidence to 
link cataract development with sun exposure is strongest for 
cortical cataracts, the form found in about 33% of subjects 
with cataracts in one survey based in rural Tanzania.18 In the 
first population-based study in an African setting (Nigeria), 
it was reported that there were 5000 per million population 
with functional low vision and 340 per million blind.19 One-
quarter of the functional low vision cases were as a result of 
corneal opacity and about 3% were as a result of pterygium. 
The prevalence of functional low vision was highest in the 
northern part of Nigeria, which is drier and sunnier than 
the south. Earlier studies in South Africa showed an annual 
incidence of cataract blindness of 0.14% with a prevalence 
of 0.6% in a rural population in KwaZulu-Natal,20 and a 
prevalence of 0.3% in rural northern Transvaal.21
Figures for the incidence and prevalence of corneal and 
other external eye diseases in sub-Saharan Africa are not 
generally available for recent years, although such disorders 
are recognised to be very common. For example, corneal 
diseases, the majority being pterygium and climatic droplet 
keratopathy, were found in more than 20% of a mixed race 
community in the north-western Cape (South Africa),22 and 
pterygium represented 9% of all new cases at an eye clinic 
in Ibadan (Nigeria)23 and 8% of ocular problems in adults 
aged 18–49 in rural Nigeria, most of which occurred in 
outdoor workers.24
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Concern has been expressed recently that sub-Saharan 
Africa is not on track to achieve the main goal of ‘VISION 
2020: The Right to Sight’ – to eliminate avoidable blindness 
by 2020.25 This imminent failure has been attributed to the 
lack of eye care teams, staff development, infrastructure and 
community programmes.25 In this context, it is disappointing 
to note that the national target for cataract surgery in South 
Africa was downgraded in 2010 from 2000 to 1500 per million 
population, when at least 2000 per million per year is 
required to eliminate cataract blindness.26 Guidance for the 
general public about protecting the eye by wearing hats with 
wide brims or sunglasses that meet an appropriate standard 
for solar UVR protection would be very helpful in reducing 
the risk of ophthalmohelioses. 
Immunosuppression and effects on 
diseases
UV-induced downregulation of immunity to a variety of 
antigens has been demonstrated in humans. The pathways 
involved are complex,27 and may involve vitamin D which 
has many immunoregulatory properties.28 The majority 
of vitamin D in most people is produced as a result of sun 
exposure. The vitamin D status of almost all populations in 
sub-Saharan Africa is unknown but, from the incomplete data 
available, is lower in South Africa compared with the tropical 
African countries.29 However, even near the equator, there 
can be a high rate of vitamin D deficiency, as demonstrated 
in adults in Ethiopia (10°N)30 and Guinea-Bissau (12°N).31 
Nutritional rickets remains prevalent in some tropical 
countries despite good sunshine exposure, although this may 
be as a result of a low calcium intake rather than a deficiency 
in vitamin D.32 
From many studies covering a variety of approaches, it 
can be concluded that UVR and/or vitamin D have the 
potential to protect against some inflammatory diseases 
and autoimmune diseases, such as multiple sclerosis, while 
decreasing the immune surveillance against skin tumours 
and infectious diseases. Each of these categories is discussed 
briefly below. 
In the context of diseases in sub-Saharan Africa, the light-
sensitive dermatoses (e.g. polymorphic light eruption where 
there is a lack of immunosuppression following sun exposure 
with development of an allergic response) do not constitute 
a major health problem as they are much less common in 
people with pigmented skin and occur rarely in regions near 
the equator.33 Similarly, multiple sclerosis is uncommon in 
the indigenous Black, Coloured or Indian people of Africa. 
In southern Africa, there is a relatively high prevalence of 
multiple sclerosis in White migrants from Europe with a 
lower prevalence in White African-born people, possibly as a 
result of the protective effect of early exposure to high levels 
of solar UVR.34 
UVR not only causes mutations but also downregulates 
immunity, an effect which is recognised to be critical in 
the development of skin tumours. For the same dose of 
UVR, fair-skinned people exhibit more DNA damage,35 
a higher production of immune mediators and a higher 
degree of immunosuppression36 than those with darker 
skins. This difference is likely to contribute to the increased 
susceptibility of individuals with fair skin to develop 
skin cancers compared with individuals with more 
pigmented skin. 
It is unclear whether UV-induced immunosuppression can 
affect the course of human infectious diseases, apart from 
triggering the reactivation from latency of herpes simplex 
virus. Some human infections exhibit a strong seasonal 
incidence. For example, influenza is highly seasonal in 
southern Africa with the peak incidence occurring in the 
drier cooler winter months: the seasonality becomes less 
pronounced with closeness to the equator.37 This pattern is 
also seen in other parts of the world, and has been attributed 
to lower vitamin D levels (and thus less effective innate 
immunity) in the winter compared with the summer in 
countries outside the tropics. Tuberculosis presents a major 
public health issue in sub-Saharan Africa with Nigeria having 
the fourth largest tuberculosis burden in the world and South 
Africa the fifth largest. Many of the new cases of tuberculosis 
are co-infections with HIV; currently sub-Saharan Africa 
accounts for 79% of the worldwide HIV–tuberculosis burden. 
From a survey of studies conducted in 11 countries or regions 
around the world (including South Africa), a seasonal pattern 
of tuberculosis is indicated with a peak in the spring and 
summer months.38 This pattern has been explained by low 
vitamin D levels in the winter leading to less effective control 
of microbial growth. Hypovitaminosis D is highly prevalent 
in tuberculosis patients and is associated with an increased 
risk of disease progression, although it is not known if the 
low level is a symptom or is causal.31 Recent research has 
considered whether vitamin D prevents reactivation of 
tuberculosis.39 With regard to HIV, while some observations 
support a role for UVR in altering the interaction of the 
virus with the host, clinical and epidemiological reports 
have not demonstrated that exposure to sunlight changes 
the course of the disease.40 Many HIV-infected people are 
vitamin D deficient but the impact of this deficiency on 
disease progression is unknown and should be investigated.
Vaccination represents a major public health strategy in sub-
Saharan Africa in attempts to control common infections, 
particularly in childhood. The potential of UVR to decrease 
the efficacy of vaccination by downregulating immunity has 
not been rigorously assessed for human vaccines although 
there are reports indicating that a less effective immune 
response is induced if the vaccine is administered in the 
summer compared with the winter, and in tropical compared 
with temperate regions.41 Perhaps of most relevance in the 
context of sub-Saharan Africa is finding that the protection 
against tuberculosis following vaccination correlates 
positively with distance from the equator.42 More severe 
UV-induced immunosuppression nearer to the equator as a 
result of the higher sun intensity could account for this result. 
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Sun-related exposure, protection, 
perceptions and awareness
The people of sub-Saharan Africa are genetically diverse: 
migrants from other countries have settled here since the 
Greeks, Romans and Arabs 3000 years ago, Europeans since 
the 1600s and Asians since the 1800s. If this heterogeneity is 
added to the range of environments and social conditions in 
sub-Saharan Africa, it can be anticipated that solar UVR will 
not have straightforward health outcomes. In addition, the 
only country to possess solar UV monitoring instruments in 
this region is South Africa, where a four-station network has 
been in operation since the early 1990s. The network aims 
to provide measured data to the media daily to inform the 
public regarding times of intense solar irradiation.
Personal sun exposure studies in sub-Saharan Africa are non-
existent, inaccessible or sparsely documented. One of the few 
studies, based in Durban (South Africa), emphasised the risk 
of sunburn and NMSC for children and outdoor workers.43 
Schoolchildren in this city experienced a mean total daily 
solar exposure of two Standard Erythemal Doses, with boys 
experiencing greater sun exposure than girls and outdoor 
physical activity being the most important determinant of 
sun exposure. 
Knowledge about sun protection is not widespread in sub-
Saharan Africa. Sunscreen use and environmental awareness 
were investigated in White Cape Town beachgoers; the 
results showed that only 50% wore sunscreen, although 90% 
of respondents cited skin cancer as a potential adverse effect 
of excess sun exposure and a few acknowledged other health 
effects.44 A survey of students attending four large tertiary 
institutions in South Africa showed that 82.3% knew that 
excessive sunlight may have harmful ocular effects, but only 
a quarter reported that they often wore sunglasses outdoors 
and 38.5% recognised that not all spectacles and contact 
lenses were protective.45
Sun protection is of special importance for individuals 
with OCA to prevent skin damage and thus lessen the risk 
of skin cancer. Most OCA cases present late in the tumour 
process and patients do not complete treatment because of 
a lack of funds or for cultural reasons. Education regarding 
protective clothing, sunscreens, indoor occupations and 
early treatment of skin lesions would be beneficial. An 
investigation in Tanzania of albinos’ understanding of skin 
cancer risk and attitudes toward sun protection showed that 
78% of respondents believed skin cancer was preventable, 
63% knew that skin cancer was related to the sun and 77% 
thought sunscreens afforded sun protection.46 Reasons for 
not wearing a hat included fashion, culture and heat. Hat-
wearing among children with OCA and visual impairment 
in northern South Africa was high (although the brim width 
was not always sufficient) and one-third used sunscreens.47 
Few sub-Saharan countries have active, sun-related 
awareness and disease prevention campaigns although 
some work has been carried out to improve primary health 
care for the management of cataracts and skin cancer. The 
non-governmental African Organisation for Research and 
Training in Cancer promotes cancer control and palliative 
care, and several sub-Saharan countries have cancer societies. 
The Cancer Association of South Africa is one of the few 
with a SunSmart programme. As outlined above, there are 
currently insufficient data to assess the extent of sun-related 
health effects and the relevance of any interventions in sub-
Saharan Africa.
Challenges and opportunities
Several challenges will need to be overcome and 
opportunities created to improve the understanding of the 
health impacts of solar UVR and to implement interventions 
locally for a sustained improvement in public health. The 
WHO INTERSUN programme is one possible mechanism. 
For this programme to be effective in sub-Saharan Africa, 
fundamental research is needed on local disease prevalence 
and incidence, exposure patterns (occupational, early life and 
recreational) and sun awareness, especially the lack thereof 
but also how awareness is affected by cultural beliefs and 
practices. The capacity to initiate and manage public health 
information to support such research is required. For example, 
a National Cancer Registry has only recently been re-instated 
in South Africa. There are additional unknowns such as 
any consequence of climate change in sub-Saharan Africa. 
Ground-based monitoring of ambient solar UVR is limited, 
mainly because of financial and personnel restrictions. Little 
research has been done on potential interactions of solar 
UVR with local diseases, such as HIV, AIDS, malaria and 
tuberculosis, and with vaccine responses. Research is also 
needed on personal solar UVR exposure and sun protection 
studies on at-risk subpopulations should be conducted. The 
potential of solar UVR to decrease the efficacy of vaccination 
by immunosuppression also merits investigation.
Sun education needs to be tailored for sub-Saharan Africa 
and its multi-ethnic subpopulations. Sun protection and 
health intervention programmes targeted at children 
with OCA have proved relatively successful48 and similar 
targeted interventions for groups at particular risk may be an 
appropriate way forward. A multidisciplinary approach for 
research and intervention programmes is essential, especially 
given the limited resources, capacity and infrastructure, and 
the high burden of communicable diseases in sub-Saharan 
Africa. Seeking health co-benefits that arise from dovetailing 
research with society and government priorities could be 
the best strategy to manage the health consequences of solar 
UVR in sub-Saharan Africa. 
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